NCT06182189 Protocollo N 2014 - Benign Prostatic Hyperplasia
| NCT ID | NCT06182189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Benign Prostatic Hyperplasia |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2014-12-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,000 participants in total. It began in 2014-12-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective observational study on the quality of life of patients with BPH under medical therapy and/or undergoing surgery.
Eligibility Criteria
Inclusion Criteria: * subjects suffering from benign prostatic hyperplasia undergoing medical therapy and/or undergoing surgery * subjects \>= 18 years old * signature of informed consent Exclusion Criteria: * subjects \< 18 years * presence of mental or physical disability that may prevent the patient from answering the questionnaires.
Contact & Investigator
Andrea Salonia, MD
PRINCIPAL INVESTIGATOR
IRCCS Ospedale San Raffaele
Frequently Asked Questions
Who can join the NCT06182189 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Benign Prostatic Hyperplasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06182189 currently recruiting?
Yes, NCT06182189 is actively recruiting participants. Contact the research team at salonia.andrea@hsr.it for enrollment information.
Where is the NCT06182189 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06182189 clinical trial?
NCT06182189 is sponsored by IRCCS San Raffaele. The principal investigator is Andrea Salonia, MD at IRCCS Ospedale San Raffaele. The trial plans to enroll 8,000 participants.